Medical isotope developer IsoRay Medical has received an additional $500,000 in institutional financing.
Together with financing that closed in November 2010 and the company's improved operations, IsoRay continues to add to its cash reserves to pursue further development of programs expanding the use of its cesium-131 brachytherapy seeds.
